Skip to main content

Table 1 Participant demographics and clinical characteristics

From: Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging

Characteristics

AD

CN

p-value

Test

 

(N = 40)

(N = 38)

  

Mean Age +/- SD

69.0 +/- 9.1

69.5 +/- 9.7

0.825

T

Mean Years of Education +/- SD

14.8 +/- 3.6

16.6 +/- 3.0

0.015

T

Mean MMSE +/- SD

19.9 +/- 7.7

29.2 +/- 1.3

1.0E-9

T

% Male

25.0

34.21

0.459

F

% Caucasian

82.5

86.8

1.00

F

% Taking Antidepressant

30.0

21.05

0.441

F

% Taking Antipsychotic

5.0

0.0

0.494

F

% Taking Anxioytic

12.5

13.2

1.00

F

% Taking Corticosteroids

2.5

13.2

0.104

F

% Taking Cholinesterase Inhibitor

37.5

0.0

<1.0E-9

F

% Taking Memantine

15.0

0.0

0.026

F

% Taking Statins

20.0

26.3

0.595

F

  1. Abbreviations: AD Alzheimer’s disease, CN Normal cognition, SD Standard Deviation, T two-sample t test, two-sided, MMSE Mini-Mental State Exam obtained at date closest to sample if not available concurrently, F Fisher’s exact test, two-sided.